High-dose recombinant interleukin-2/verapamil combination in advanced cancer

Eur J Cancer. 1996 Jul;32A(8):1436-7. doi: 10.1016/0959-8049(96)00126-8.
No abstract available

Publication types

  • Clinical Trial
  • Clinical Trial, Phase I
  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Antineoplastic Agents / therapeutic use*
  • Calcium Channel Blockers / therapeutic use*
  • Female
  • Humans
  • Interleukin-2 / therapeutic use*
  • Male
  • Middle Aged
  • Neoplasms / therapy*
  • Recombinant Proteins / therapeutic use
  • Verapamil / therapeutic use*

Substances

  • Antineoplastic Agents
  • Calcium Channel Blockers
  • Interleukin-2
  • Recombinant Proteins
  • Verapamil